清水宏 皮膚の構造と機能 -皮膚とは-. In あたらしい皮膚科学; 中山書店: 東京,
2018; Vol. 1章, pp. 1–3.
2.
清水宏 皮膚の構造と機能 -表皮-. In あたらしい皮膚科学; 中山書店: 東京,
2018; pp. 3–7.
3.
清水宏 皮膚の構造と機能 -真皮-. In あたらしい皮膚科学; 中山書店: 東京,
2018; pp. 13–17.
4.
小川令 瘢痕・ケロイドはここまで治せる; 克誠堂: 東京, 2015;
5.
Ogawa, R. Keloid and hypertrophic scars are the result of chronic inflammation
in the reticular dermis. Int. J. Mol. Sci. 2017, 18, doi:10.3390/ijms18030606.
6.
波利井清紀 形成外科ADVANCE SERIES I-3 創傷の治療最近の進歩 ： 改訂第
2版; 森口隆彦, Ed.; 克誠堂: 東京, 2005;
7.
Desmouliere, A.; Redard, M.; Darby, I.; Gabbiani, G. Apoptosis mediates the
decrease in cellularity during the transition between granulation tissue and scar.
Am. J. Pathol. 1995, 146, 56.
8.
Gauglitz, G.G.; Korting, H.C.; Pavicic, T.; Ruzicka, T.; Jeschke, M.G.
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and
Emerging Treatment Strategies. Mol. Med. 2011, 17, 113,
doi:10.2119/MOLMED.2009.00153.
9.
Schouten, H.J.; Nieuwenhuis, M.K.; van Baar, M.E.; van der Schans, C.P.;
Niemeijer, A.S.; van Zuijlen, P.P.M. The degree of joint range of motion
limitations after burn injuries during recovery. Burns 2022, 48, 309–318,
doi:10.1016/j.burns.2021.01.003.
10.
Oosterwijk, A.M.; Mouton, L.J.; Schouten, H.; Disseldorp, L.M.; van der Schans,
C.P.; Nieuwenhuis, M.K. Prevalence of scar contractures after burn: A
systematic review. Burns 2017, 43, 41–49, doi:10.1016/J.BURNS.2016.08.002.
11.
Zhu, Z.; Kong, W.; Wang, H.; Xiao, Y.; Shi, Y.; Gan, L.; Sun, Y.; Tang, H.; Xia, Z.
Prevalence and predictors of scar contracture-associated re-hospitalisation
among burn inpatients in China. Sci. Rep. 2021, 11, 1–10, doi:10.1038/s41598021-94432-w.
12.
Peacock EEJr Wound repair; W.B. Saunders: Philadelphia, 1984;
13.
WATTS, G.T.; GRILLO, H.C.; GROSS, J. Studies in Wound Healing: II. The
Role of Granulation Tissue in Contraction. Ann. Surg. 1958, 148, 153–160,
doi:10.1097/00000658-195808000-00002.
14.
Yang, Y.; Perdue, J.F. Contractile Proteins of Cultured Cells. J. Biol. Chem.
72
1972, 247, 4503–4509, doi:10.1016/s0021-9258(19)45015-1.
15.
Lazarides, E.; Weber, K. Actin antibody: the specific visualization of actin
filaments in non-muscle cells. Proc. Natl. Acad. Sci. U. S. A. 1974, 71, 2268–
2272, doi:10.1073/PNAS.71.6.2268.
16.
Gabbiani, G.; Ryan, G.B.; Majno, G. Presence of modified fibroblasts in
granulation tissue and their possible role in wound contraction. Experientia 1971,
27, 549–550, doi:10.1007/BF02147594.
17.
Baur, P.S.; Larson, D.L.; Stacey, T.R. The observation of myofibroblasts in
hypertrophic scars. Surg. Gynecol. Obstet. 1975, 141, 22–26.
18.
Rudolph, R.; Vande Berg, J. The myofibroblast in Dupuytren’s contracture. Hand
Clin. 1991, 7, 683–692, doi:10.1016/s0749-0712(21)00907-0.
19.
Shin, D.; Minn, K.W. The effect of myofibroblast on contracture of hypertrophic
scar. Plast. Reconstr. Surg. 2004, 113, 633–640,
doi:10.1097/01.PRS.0000101530.33096.5B.
20.
Monika, P.; Waiker, P.V.; Chandraprabha, M.N.; Rangarajan, A.; Murthy, K.N.C.
Myofibroblast progeny in wound biology and wound healing studies. Wound
Repair Regen. 2021, 29, 531–547, doi:10.1111/wrr.12937.
21.
Shibuya, Y.; Hokugo, A.; Okawa, H.; Kondo, T.; Khalil, D.; Wang, L.; Roca, Y.;
Clements, A.; Sasaki, H.; Berry, E.; et al. Therapeutic downregulation of
neuronal PAS domain 2 (Npas2) promotes surgical skin wound healing. Elife
2022, 11, 71074, doi:10.7554/eLife.71074.
22.
Stekelenburg, C.M.; Marck, R.E.; Tuinebreijer, W.E.; De Vet, H.C.W.; Ogawa,
R.; Van Zuijlen, P.P.M. A systematic review on burn scar contracture treatment:
searching for evidence. J. Burn Care Res. 2015, 36, e153–e161,
doi:10.1097/BCR.0000000000000106.
23.
Conway, H.C.; Gillette, R.W.; Findley, A.F. Observations on the behavior of
human keloids in vitro. Plast. Reconstr. Surg. Transplant. Bull. 1959, 24, 229–
237, doi:10.1097/00006534-195909000-00001.
24.
Russell, J.D.; Witt, W.S. Cell size and growth characteristics of cultured
fibroblasts isolated from normal and keloid tissue. Plast. Reconstr. Surg. 1976,
57, 207–212, doi:10.1097/00006534-197602000-00014.
25.
Diegelmann, R.F.; Cohen, I.K.; McCoy, B.J. Growth kinetics and collagen
synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J. Cell.
Physiol. 1979, 98, 341–346, doi:10.1002/JCP.1040980210.
26.
Luo, L.; Li, J.; Liu, H.; Jian, X.; Zou, Q.; Zhao, Q.; Le, Q.; Chen, H.; Gao, X.; He,
C. Adiponectin Is Involved in Connective Tissue Growth Factor-Induced
73
Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid
Fibroblasts. Int. J. Mol. Sci. 2017, 18, doi:10.3390/IJMS18051044.
27.
Lei, R.; Zhang, S.; Wang, Y.; Dai, S.; Sun, J.; Zhu, C. Metformin Inhibits
Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1α/PKM2
Signaling Pathway. Int. J. Med. Sci. 2019, 16, 960–966, doi:10.7150/ijms.32157.
28.
Mun, J.H.; Kim, Y.M.; Kim, B.S.; Kim, J.H.; Kim, M.B.; Ko, H.C. Simvastatin
inhibits transforming growth factor-β1-induced expression of type I collagen,
CTGF, and α-SMA in keloid fibroblasts. Wound Repair Regen. 2014, 22, 125–
133, doi:10.1111/WRR.12136.
29.
Kuwahara, H.; Tosa, M.; Egawa, S.; Murakami, M.; Mohammad, G.; Ogawa, R.
Examination of Epithelial Mesenchymal Transition in Keloid Tissues and
Possibility of Keloid Therapy Target. Plast. Reconstr. surgery. Glob. open 2016,
4, doi:10.1097/GOX.0000000000001138.
30.
Kuehlmann, B.; Bonham, C.A.; Zucal, I.; Prantl, L.; Gurtner, G.C.
Mechanotransduction in Wound Healing and Fibrosis. J. Clin. Med. 2020, 9,
doi:10.3390/JCM9051423.
31.
Suarez, E.; Syed, F.; Rasgado, T.A.; Walmsley, A.; Mandal, P.; Bayat, A. Skin
equivalent tensional force alters keloid fibroblast behavior and phenotype.
Wound Repair Regen. 2014, 22, 557–568, doi:10.1111/wrr.12215.
32.
Pedersen, J.A.; Swartz, M.A. Mechanobiology in the third dimension. Ann.
Biomed. Eng. 2005, 33, 1469–1490, doi:10.1007/S10439-005-8159-4.
33.
Zomer, H.D.; Trentin, A.G. Skin wound healing in humans and mice: Challenges
in translational research. J. Dermatol. Sci. 2018, 90, 3–12,
doi:10.1016/J.JDERMSCI.2017.12.009.
34.
Gurtner, G.C.; Wong, V.W.; Sorkin, M.; Glotzbach, J.P.; Longaker, M.T. Surgical
approaches to create murine models of human wound healing. J. Biomed.
Biotechnol. 2011, 2011, doi:10.1155/2011/969618.
35.
Supp, D.M. Animal Models for Studies of Keloid Scarring. Adv. Wound Care
2019, 8, 77, doi:10.1089/WOUND.2018.0828.
36.
Galiano, R.D.; Michaels V, J.; Dobryansky, M.; Levine, J.P.; Gurtner, G.C.
Quantitative and reproducible murine model of excisional wound healing. Wound
Repair Regen. 2004, 12, 485–492, doi:10.1111/J.1067-1927.2004.12404.X.
37.
Aarabi, S.; Bhatt, K.A.; Shi, Y.; Paterno, J.; Chang, E.I.; Loh, S.A.; Holmes, J.W.;
Longaker, M.T.; Yee, H.; Gurtner, G.C. Mechanical load initiates hypertrophic
scar formation through decreased cellular apoptosis. FASEB J. 2007, 21, 3250–
3261, doi:10.1096/FJ.07-8218COM.
74
38.
Neves, L.M.G.; Wilgus, T.A.; Bayat, A. In Vitro, Ex Vivo, and In Vivo Approaches
for Investigation of Skin Scarring: Human and Animal Models. Adv. wound care
2022, doi:10.1089/WOUND.2021.0139.
39.
Bell, E.; Ivarsson, B.; Merrill, C. Production of a tissue-like structure by
contraction of collagen lattices by human fibroblasts of different proliferative
potential in vitro. Proc. Natl. Acad. Sci. U. S. A. 1979, 76, 1274,
doi:10.1073/PNAS.76.3.1274.
40.
Dallon, J.C.; Ehrlich, H.P. A review of fibroblast-populated collagen lattices.
Wound Repair Regen. 2008, 16, 472–479, doi:10.1111/j.1524475X.2008.00392.x.
41.
Ehrlich, H.P.; Moyer, K.E. Cell-populated collagen lattice contraction model for
the investigation of fibroblast collagen interactions. Methods Mol. Biol. 2013,
1037, 45–58, doi:10.1007/978-1-62703-505-7_3.
42.
Li, Z.J.; Kim, S.M. The application of the starfish hatching enzyme for the
improvement of scar and keloid based on the fibroblast-populated collagen
lattice. Appl. Biochem. Biotechnol. 2014, 173, 989–1002, doi:10.1007/s12010014-0901-7.
43.
Saito, M.; Maeda, T.; Setoguchi, Y.; Yamazaki, M.; Matsumura, H.; Tsuboi, R.
Pirfenidone suppresses keloid fibroblast-embedded collagen gel contraction.
Arch. Dermatol. Res. 2012, 304, 217–222, doi:10.1007/s00403-011-1184-2.
44.
Liu, J.; Guo, X.; Ren, X.; Tian, H.; Liang, Y.; Luo, Z.; Wang, W.; Wang, Y.;
Zhang, D.; Huang, Y.; et al. A novel FPCL model producing directional
contraction through induction of fibroblast alignment by biphasic pulse direct
current electric field. Exp. Cell Res. 2018, 371, 426–434,
doi:10.1016/j.yexcr.2018.09.003.
45.
da Silva Meirelles, L.; Fontes, A.M.; Covas, D.T.; Caplan, A.I. Mechanisms
involved in the therapeutic properties of mesenchymal stem cells. Cytokine
Growth Factor Rev. 2009, 20, 419–427, doi:10.1016/j.cytogfr.2009.10.002.
46.
Ding, D.C.; Shyu, W.C.; Lin, S.Z. Mesenchymal stem cells. Cell Transplant.
2011, 20, 5–14, doi:10.3727/096368910X.
47.
Lee, D.E.; Ayoub, N.; Agrawal, D.K. Mesenchymal stem cells and cutaneous
wound healing: Novel methods to increase cell delivery and therapeutic efficacy.
Stem Cell Res. Ther. 2016, 7, 1–8, doi:10.1186/s13287-016-0303-6.
48.
Bojanic, C.; To, K.; Hatoum, A.; Shea, J.; Seah, K.T.M.; Khan, W.; Malata, C.M.
Mesenchymal stem cell therapy in hypertrophic and keloid scars. Cell Tissue
Res. 2020, doi:10.1007/s00441-020-03361-z.
75
49.
Frese, L.; Dijkman, P.E.; Hoerstrup, S.P. Adipose Tissue-Derived Stem Cells in
Regenerative Medicine. Transfus. Med. Hemotherapy 2016, 43, 268,
doi:10.1159/000448180.
50.
Chen, H.; Hou, K.; Wu, Y.; Liu, Z. Use of Adipose Stem Cells Against
Hypertrophic Scarring or Keloid. Front. Cell Dev. Biol. 2022, 9, 1–6,
doi:10.3389/fcell.2021.823694.
51.
Han, B.; Fan, J.; Liu, L.; Tian, J.; Gan, C.; Yang, Z.; Jiao, H.; Zhang, T.; Liu, Z.;
Zhang, H. Adipose-derived mesenchymal stem cells treatments for fibroblasts of
fibrotic scar via downregulating TGF-β1 and Notch-1 expression enhanced by
photobiomodulation therapy. Lasers Med. Sci. 2019, 34, 1–10,
doi:10.1007/s10103-018-2567-9.
52.
Mankuzhy, P.D.; Ramesh, S.T.; Thirupathi, Y.; Mohandas, P.S.; Chandra, V.;
Sharma, T.G. The preclinical and clinical implications of fetal adnexa derived
mesenchymal stromal cells in wound healing therapy. Wound Repair Regen.
2021, 29, 347–369, doi:10.1111/wrr.12911.
53.
Tucci-Viegas, V.M.; Hochman, B.; Frana, J.P.; Ferreira, L.M. Keloid explant
culture: A model for keloid fibroblasts isolation and cultivation based on the
biological differences of its specific regions. Int. Wound J. 2010, 7, 339–348,
doi:10.1111/j.1742-481X.2010.00698.x.
54.
Sugii, S.; Kida, Y.; Berggren, W.T.; Evans, R.M. Feeder-dependent and feederindependent iPS cell derivation from human and mouse adipose stem cells. Nat.
Protoc. 2011, 6, 346–358, doi:10.1038/NPROT.2010.199.
55.
陽一郎渋谷 脂肪組織由来細胞を用いた腱組織再生迅速化に関する研究,
Tsukuba, 2015.
56.
Mori, N.; Morimoto, Y.; Takeuchi, S. Skin integrated with perfusable vascular
channels on a chip. Biomaterials 2017, 116, 48–56,
doi:10.1016/j.biomaterials.2016.11.031.
57.
Hsieh, S.C.; Wu, C.C.; Hsu, S.L.; Feng, C.H.; Yen, J.H. Gallic acid attenuates
TGF-β1-stimulated collagen gel contraction via suppression of RhoA/Rho-kinase
pathway in hypertrophic scar fibroblasts. Life Sci. 2016, 161, 19–26,
doi:10.1016/j.lfs.2016.07.011.
58.
Schindelin, J.; Arganda-Carreras, I.; Frise, E.; Kaynig, V.; Longair, M.; Pietzsch,
T.; Preibisch, S.; Rueden, C.; Saalfeld, S.; Schmid, B.; et al. Fiji: An open-source
platform for biological-image analysis. Nat. Methods 2012, 9, 676–682.
59.
Dobin, A.; Davis, C.A.; Schlesinger, F.; Drenkow, J.; Zaleski, C.; Jha, S.; Batut,
P.; Chaisson, M.; Gingeras, T.R. STAR: ultrafast universal RNA-seq aligner.
76
Bioinformatics 2013, 29, 15–21, doi:10.1093/BIOINFORMATICS/BTS635.
60.
Li, B.; Dewey, C.N. RSEM: accurate transcript quantification from RNA-Seq data
with or without a reference genome. BMC Bioinformatics 2011, 12,
doi:10.1186/1471-2105-12-323.
61.
Team, R.C. R: A language and Environment for Statistical Computing. Available
online: https://www.r-project.org/.
62.
Robinson, M.D.; McCarthy, D.J.; Smyth, G.K. edgeR: a Bioconductor package
for differential expression analysis of digital gene expression data. Bioinformatics
2010, 26, 139–140, doi:10.1093/BIOINFORMATICS/BTP616.
63.
McCarthy, D.J.; Chen, Y.; Smyth, G.K. Differential expression analysis of
multifactor RNA-Seq experiments with respect to biological variation. Nucleic
Acids Res. 2012, 40, 4288–4297, doi:10.1093/NAR/GKS042.
64.
Huang, D.W.; Sherman, B.T.; Lempicki, R.A. Bioinformatics enrichment tools:
paths toward the comprehensive functional analysis of large gene lists. Nucleic
Acids Res. 2009, 37, 1–13, doi:10.1093/NAR/GKN923.
65.
Huang, D.W.; Sherman, B.T.; Lempicki, R.A. Systematic and integrative analysis
of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4,
44–57, doi:10.1038/NPROT.2008.211.
66.
Fresno, C.; Fernández, E.A. RDAVIDWebService: a versatile R interface to
DAVID. Bioinformatics 2013, 29, 2810–2811,
doi:10.1093/BIOINFORMATICS/BTT487.
67.
Yu, G.; Wang, L.G.; Han, Y.; He, Q.Y. clusterProfiler: an R package for
comparing biological themes among gene clusters. OMICS 2012, 16, 284–287,
doi:10.1089/OMI.2011.0118.
68.
Mootha, V.K.; Lindgren, C.M.; Eriksson, K.F.; Subramanian, A.; Sihag, S.; Lehar,
J.; Puigserver, P.; Carlsson, E.; Ridderstråle, M.; Laurila, E.; et al. PGC-1alpharesponsive genes involved in oxidative phosphorylation are coordinately
downregulated in human diabetes. Nat. Genet. 2003, 34, 267–273,
doi:10.1038/NG1180.
69.
Subramanian, A.; Tamayo, P.; Mootha, V.K.; Mukherjee, S.; Ebert, B.L.; Gillette,
M.A.; Paulovich, A.; Pomeroy, S.L.; Golub, T.R.; Lander, E.S.; et al. Gene set
enrichment analysis: a knowledge-based approach for interpreting genome-wide
expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102, 15545–15550,
doi:10.1073/PNAS.0506580102.
70.
Kanda, Y. Investigation of the freely available easy-to-use software
‘EZR’ for medical statistics. Bone Marrow Transplant. 2013,
77
doi:10.1038/bmt.2012.244.
71.
Shinde, A. V.; Humeres, C.; Frangogiannis, N.G. The role of α-smooth muscle
actin in fibroblast-mediated matrix contraction and remodeling. Biochim.
Biophys. acta. Mol. basis Dis. 2017, 1863, 298–309,
doi:10.1016/J.BBADIS.2016.11.006.
72.
Xue, H.; McCauley, R.L.; Zhang, W. Elevated interleukin-6 expression in keloid
fibroblasts. J. Surg. Res. 2000, 89, 74–77, doi:10.1006/jsre.1999.5805.
73.
Zhang, T.; Wang, X.F.; Wang, Z.C.; Lou, D.; Fang, Q.Q.; Hu, Y.Y.; Zhao, W.Y.;
Zhang, L.Y.; Wu, L.H.; Tan, W.Q. Current potential therapeutic strategies
targeting the TGF-β/Smad signaling pathway to attenuate keloid and
hypertrophic scar formation. Biomed. Pharmacother. 2020, 129, 110287,
doi:10.1016/j.biopha.2020.110287.
74.
Wulandari, E.; Jusman, S.W.A.; Moenadjat, Y.; Jusuf, A.A.; Sadikin, M.
Expressions of collagen I and III in hypoxic keloid tissue. Kobe J. Med. Sci.
2016, 62, E58–E69.
75.
Hashimoto, T.; Kojima, K.; Tamada, Y. Higher gene expression related to wound
healing by fibroblasts on silk fibroin biomaterial than on collagen. Molecules
2020, 25, doi:10.3390/MOLECULES25081939.
76.
Ogawa, R.; Dohi, T.; Tosa, M.; Aoki, M.; Akaishi, S. The latest strategy for keloid
and hypertrophic scar prevention and treatment: The nippon medical school
(NMS) protocol. J. Nippon Med. Sch. 2021, 88, 2–9,
doi:10.1272/jnms.JNMS.2021_88-106.
77.
Sato, C.; Yamamoto, Y.; Funayama, E.; Furukawa, H.; Oyama, A.; Murao, N.;
Hosono, H.; Kawakubo, K.; Sakamoto, N.; Ohnishi, S. Conditioned medium
obtained from amnion-derived mesenchymal stem cell culture prevents
activation of keloid fibroblasts. Plast. Reconstr. Surg. 2018, 141, 390–398,
doi:10.1097/PRS.0000000000004068.
78.
Chen, Y.; Liao, N.; Lu, F.; Peng, H.; Gao, J. The role of Duffy antigen receptor
for chemokines in keloids. Gene 2015, 570, 44–49,
doi:10.1016/j.gene.2015.05.071.
79.
Ferreira, A.M.; Takagawa, S.; Fresco, R.; Zhu, X.; Varga, J.; DiPietro, L.A.
Diminished induction of skin fibrosis in mice with MCP-1 deficiency. J. Invest.
Dermatol. 2006, 126, 1900–1908, doi:10.1038/sj.jid.5700302.
80.
Albrengues, J.; Bourget, I.; Pons, C.; Butet, V.; Hofman, P.; Tartare-Deckert, S.;
Feral, C.C.; Meneguzzi, G.; Gaggioli, C. LIF Mediates Proinvasive Activation of
Stromal Fibroblasts in Cancer. Cell Rep. 2014, 7, 1664–1678,
78
doi:10.1016/J.CELREP.2014.04.036.
81.
Keskin, E.S.; Keskin, E.R.; Öztürk, M.B.; Çakan, D. The Effect of MMP-1 on
Wound Healing and Scar Formation. Aesthetic Plast. Surg. 2021, 45, 2973–
2979, doi:10.1007/S00266-021-02369-2.
82.
Rong, S.; Li, C.; Li, S.; Wu, S.; Sun, F. Genetically modified adipose-derived
stem cells with matrix metalloproteinase 3 promote scarless cutaneous repair.
Dermatol. Ther. 2020, 33, doi:10.1111/DTH.14112.
83.
Yoshimura, K.; Shigeura, T.; Matsumoto, D.; Sato, T.; Takaki, Y.; Aiba-Kojima,
E.; Sato, K.; Inoue, K.; Nagase, T.; Koshima, I.; et al. Characterization of freshly
isolated and cultured cells derived from the fatty and fluid portions of liposuction
aspirates. J. Cell. Physiol. 2006, 208, 64–76, doi:10.1002/JCP.20636.
84.
Aronowitz, J.A.; Ellenhorn, J.D.I. Adipose stromal vascular fraction isolation: a
head-to-head comparison of four commercial cell separation systems. Plast.
Reconstr. Surg. 2013, 132, doi:10.1097/PRS.0B013E3182A80652.
85.
Mora, E.; Guglielmotti, A.; Biondi, G.; Sassone-Corsi, P. Bindarit: An antiinflammatory small molecule that modulates the NFκB pathway. Cell Cycle 2012,
11, 159–169, doi:10.4161/cc.11.1.18559.
86.
Paccosi, S.; Giachi, M.; Di Gennaro, P.; Guglielmotti, A.; Parenti, A. The
chemokine (C-C motif) ligand protein synthesis inhibitor bindarit prevents
cytoskeletal rearrangement and contraction of human mesangial cells. Cytokine
2016, 85, 92–100, doi:10.1016/j.cyto.2016.06.012.
87.
Paccosi, S.; Musilli, C.; Mangano, G.; Guglielmotti, A.; Parenti, A. The monocyte
chemotactic protein synthesis inhibitor bindarit prevents mesangial cell
proliferation and extracellular matrix remodeling. Pharmacol. Res. 2012, 66,
526–535, doi:10.1016/j.phrs.2012.09.006.
88.
Kamamoto, F.; Oliveira Paggiaro, A.; Rodas, A.; Roma Herson, M.; Beatriz
Mathor, M.; Castro Ferreira, M. A wound contraction experimental model for
studying keloids and wound-healing modulators. Artif. Organs 2003, 27, 701–
705, doi:10.1046/j.1525-1594.2003.07277.x.
89.
Bell, E.; Ehrlich, H.P.; Buttle, D.J.; Nakatsuji, T. Living tissue formed in vitro and
accepted as skin-equivalent tissue of full thickness. Science 1981, 211, 1052–
1054, doi:10.1126/SCIENCE.7008197.
90.
Mori, N.; Akagi, Y.; Imai, Y.; Takayama, Y.; Kida, Y.S. Fabrication of Perfusable
Vascular Channels and Capillaries in 3D Liver-like Tissue. Sci. Rep. 2020, 10,
doi:10.1038/S41598-020-62286-3.
91.
Derderian, C.A.; Bastidas, N.; Lerman, O.Z.; Bhatt, K.A.; Lin, S.E.; Voss, J.;
79
Holmes, J.W.; Levine, J.P.; Gurtner, G.C. Mechanical strain alters gene
expression in an in vitro model of hypertrophic scarring. Ann. Plast. Surg. 2005,
55, 69–75, doi:10.1097/01.SAP.0000168160.86221.E9.
92.
Strem, B.M.; Hicok, K.C.; Zhu, M.; Wulur, I.; Alfonso, Z.; Schreiber, R.E.; Fraser,
J.K.; Hedrick, M.H. Multipotential differentiation of adipose tissue-derived stem
cells. Keio J. Med. 2005, 54, 132–141, doi:10.2302/KJM.54.132.
93.
Gir, P.; Oni, G.; Brown, S.A.; Mojallal, A.; Rohrich, R.J. Human adipose stem
cells: current clinical applications. Plast. Reconstr. Surg. 2012, 129, 1277–1290,
doi:10.1097/PRS.0B013E31824ECAE6.
94.
O’Halloran, N.; Courtney, D.; Kerin, M.J.; Lowery, A.J. Adipose-Derived Stem
Cells in Novel Approaches to Breast Reconstruction: Their Suitability for Tissue
Engineering and Oncological Safety. Breast Cancer (Auckl). 2017, 11,
doi:10.1177/1178223417726777.
95.
Gardin, C.; Ferroni, L.; Bellin, G.; Rubini, G.; Barosio, S.; Zavan, B. Therapeutic
Potential of Autologous Adipose-Derived Stem Cells for the Treatment of Liver
Disease. Int. J. Mol. Sci. 2018, 19, doi:10.3390/IJMS19124064.
96.
Rombouts, W.J.C.; Ploemacher, R.E. Primary murine MSC show highly efficient
homing to the bone marrow but lose homing ability following culture. Leukemia
2003, 17, 160–170, doi:10.1038/SJ.LEU.2402763.
97.
Wolf, P. The nature and significance of platelet products in human plasma. Br. J.
Haematol. 1967, 13, 269–288, doi:10.1111/J.1365-2141.1967.TB08741.X.
98.
Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O.
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of
genetic exchange between cells. Nat. Cell Biol. 2007, 9, 654–659,
doi:10.1038/NCB1596.
99.
Hu, L.; Wang, J.; Zhou, X.; Xiong, Z.; Zhao, J.; Yu, R.; Huang, F.; Zhang, H.;
Chen, L. Exosomes derived from human adipose mensenchymal stem cells
accelerates cutaneous wound healing via optimizing the characteristics of
fibroblasts. Sci. Rep. 2016, 6, 1–11, doi:10.1038/srep32993.
100. Wu, Z.Y.; Zhang, H.J.; Zhou, Z.H.; Li, Z.P.; Liao, S.M.; Wu, Z.Y.; Huang, H.H.;
Shi, Y.C. The effect of inhibiting exosomes derived from adipose-derived stem
cells via the TGF-β1/Smad pathway on the fibrosis of keloid fibroblasts. Gland
Surg. 2021, 10, 1046–1056, doi:10.21037/gs-21-4.
80
第9章
謝辞
本論文の作成にあたり、御指導を賜りました関堂充教授に心から感謝いたします。ま
た、実験にあたり多大なる御指導と御協力、御助言を頂いた国立研究開発法人産業技術
総合研究所の細胞分子工学研究部門ステムセルバイオテクノロジー研究グループ、木田
泰之チーム長、森宜仁博士、二橋佑磨博士、熊谷雄太郎博士、および関連の諸先生方に
厚く御礼を申し上げます。
81
第 10 章
出典
本学位論文では Biomedicines, 10(10):2388, 2022
doi.org/10.3390/biomedicines10102388 に掲載された論文の内容を、
Multidisciplinary Digital Publishing Institute（MDPI）社の規定にしたがって再利用して
いる。
82
...
論文の公開元へ
